首页> 外文期刊>The Journal of Antimicrobial Chemotherapy >OXA-1 beta-lactamase and non-susceptibility to penicillin/beta-lactamase inhibitor combinations among ESBL-producing Escherichia coli
【24h】

OXA-1 beta-lactamase and non-susceptibility to penicillin/beta-lactamase inhibitor combinations among ESBL-producing Escherichia coli

机译:EXA-1β-内酰胺酶和对ESBL-生成的大肠杆菌中的青霉素/β-内酰胺酶抑制剂组合的不敏感性

获取原文
获取原文并翻译 | 示例
           

摘要

Background: ESBL-producing Escherichia coli have expanded globally since the turn of the century and present a major public health issue. Their in vitro susceptibility to penicillin/inhibitor combinations is variable, and clinical use of these combinations against ESBL producers remains controversial. We hypothesized that this variability related to co-production of OXA-1 penicillinase.
机译:背景:自世纪之交以来,ESBL-生产大肠杆菌在全球范围内扩大,并提出了一个主要的公共卫生问题。 它们对青霉素/抑制剂组合的体外易感性是可变的,并且这些组合对ESBL生产者的临床应用仍然存在争议。 我们假设这种与氧气生成相关的这种可变性氧气氧化酶。

著录项

  • 来源
  • 作者单位

    PHE Natl Infect Serv Antimicrobial Resistance &

    Healthcare Associated London England;

    PHE Natl Infect Serv Antimicrobial Resistance &

    Healthcare Associated London England;

    PHE Field Serv Liverpool Merseyside England;

    PHE Natl Infect Serv Antimicrobial Resistance &

    Healthcare Associated London England;

    Cardiff Univ Heath Pk Campus Cardiff S Glam Wales;

    Queen Mary Univ London Blizard Inst London England;

    Hlth Protect Scotland Glasgow Lanark Scotland;

    PHE Natl Infect Serv Antimicrobial Resistance &

    Healthcare Associated London England;

    PHE Natl Infect Serv Antimicrobial Resistance &

    Healthcare Associated London England;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 治疗学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号